Stockwinners Market Radar for August 14, 2020 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

18:04 EDT Celanese announces Acetyl Intermediates price increase - Celanese will increase list and off-list selling prices for the following acetyl intermediates products. The price increases are for orders shipped and will be effective immediately, or as contracts otherwise allow, and are incremental to any previously announced increases. The company will increase the price on Vinyl Acetate Monomer by 3c per lb in U.S. and Canada and also increase prices on Ethyl Acetate and Butyl Acetate by $50 per MT in Asia outside China.

17:42 EDT Hertz CFO Jamere Jackson resigns, R. Eric Esper to succeed - Hertz announced that CFO Jamere Jackson, has resigned to pursue a new opportunity. Jackson will remain with Hertz until September 11 to assist in the transition of his responsibilities. The company also announced the promotion of R. Eric Esper to Executive Vice President of Finance, CFO, and Kenny Cheung to Executive Vice President of Finance, Chief Operational Finance and Restructuring Officer, effective immediately. They will report directly to Paul Stone, Hertz's President and CEO, as will the company's Treasurer, Scott Massengill. Esper has served as Senior Vice President and Chief Accounting Officer of Hertz since November 2018. He previously served as Vice President and Controller of the company beginning March 2018. From July 2010 to March 2018, Esper held a variety of financial leadership roles with Norwegian Cruise Line (NCLH), most recently as Vice President, Brand Finance & Strategy, and Vice President and Controller. Prior to that, Esper was with PricewaterhouseCooper.

17:34 EDT Lockheed Martin awarded $62B Air Force contract for F-16 production - Lockheed Martin has been awarded a $62B ten-year, indefinite-delivery/indefinite-quantity, or IDIQ, fixed-price-incentive contract for new production of F-16 Foreign Military Sale, or FMS, aircraft. The total value for the initial delivery order is $4.94B and will be awarded on the same date. The initial delivery order is for 90 aircraft, including both the pre-priced recurring core configuration costs at $2.86B and the engineering change proposal/undefinitized contract action for the non-recurring costs not-to-exceed $2.08B obligated at approximately $1.02B. Work will be primarily performed in Greenville, South Carolina and Fort Worth, Texas, and is expected to be completed December 31, 2026. This contract involves 100% FMS to FMS partner nations and is the result of a sole-source acquisition. FMS funds in the amount of $3.88B are being obligated at the time of award. Air Force Life Cycle Management Center is the contracting activity.

17:20 EDT Trian takes new stakes in Sysco, Mondelez, omits confidential information - Nelson Peltz's Trian Fund Management disclosed in an SEC filing its holdings as of June 30, 2020. Trian's two new buys during the second quarter were Sysco (SYY) and Mondelez (MDLZ). Trian reduced its stake in four holdings, Procter & Gamble (PG), Bank of New York Mellon Corp (BK), General Electric (GE), and NVent Electric (NVT). Trian's top holdings as of June 30, in order of size, were Sysco, Procter & Gamble, Mondelez, Wendy's (WEN), and General Electric. Additionally, Trian Fund Management disclosed that it omitted confidential information in its quarterly filing, and that it would file that information separately with the SEC.

17:13 EDT Elliott Management takes stakes in Welltower, Forescout - Paul Singer's Elliott Management disclosed in an SEC filing its holdings as of June 30, 2020. Elliott Management's three new buys during the second quarter included, by size of position, Welltower (WELL) and Forescout Technologies (FSCT). Elliott Management exited 11 positions during the quarter, including by size of previous position, Roadrunner Transportation Systems (RRTS), Element Solutions (ESI), and New Relic (NEWR). Elliott Management increased its stake in three holdings, Dell Technologies (DELL), Twitter (TWTR), and Ryanair (RYAAY). Elliott Management's top holdings as of June 30, in order of size, were Dell, eBay (EBAY), Marathon Petroleum (MPC), Nielsen Holdings (NLSN), and Welltower.

17:01 EDT Greenlight Capital exits Altice, takes stake in Atlas Air - David Einhorn's Greenlight Capital disclosed in an SEC filing its holdings as of June 30, 2020. Greenlight Capital's 11 new buys during the second quarter included, by size of position, Atlas Air Worldwide (AAWW), Teck Resources (TECK), Resideo (REZI), and Jack in the Box (JACK). Greenlight Capital exited 11 positions during the quarter, including by size of previous position, Altice USA (ATUS), Adient (ADNT), Centene (CNC), Altria (MO), and Paychex (PAYX). Greenlight Capital increased its stake in four holdings, including by size of previous position, AerCap (AER), Change Healthcare (CHNG), and Neubase (NBSE). Greenlight Capital reduced its stake in three holdings, CNX Resources (CNX),. Exela Technologies (XELA), and Chemours (CC). Greenlight Capital's top holdings as of June 30, in order of size, were Green Brick (GRBK), AerCap, Brighthouse Financial (BHF), and Atlas Air Worldwide.

16:37 EDT JANA Partners exits stake in Jack in the Box - In JANA Partners' 13F filing, the hedge fund manager disclosed it exited its 807K share position in Jack in the Box (JACK).

16:32 EDT Cboe Global Markets increases quarterly cash dividend 17% to 42c per share - Cboe Global Markets announced its board has declared an increased quarterly cash dividend of 42c per share of common stock for Q3, representing a 17% increase from the prior quarter's dividend of 36c per share. The Q30 dividend is payable on September 15 to stockholders of record as of August 28.

16:23 EDT Appaloosa takes positions in AT&T, Visa, cuts stake in Tesla - David Tepper's Appaloosa Management disclosed in an SEC filing its holdings as of June 30, 2020. Appaloosa's 12 new buys during the second quarter included, by size of position, AT&T (T), Visa (V), Mastercard (MA), PayPal (PYPL), and Walt Disney (DIS). Appaloosa exited five positions during the quarter, including Intelsat (I). Appaloosa increased its stake in 11 holdings, including by size of previous position, T-Mobile (TMUS), Alibaba (BABA), Micron (MU), HCA Healthcare (HCA), and Microsoft (MSFT). Appaloosa reduced its stake in 14 holdings, including by size of previous position, PG&E (PCG), Unitedhealth (UNH), Tesla (TSLA), Humana (HUM), and Vistra (VST). Appaloosa's top holdings as of June 30, in order of size, were Alibaba, Amazon (AMZN), T-Mobile, Facebook (FB), and Micron.

16:02 EDT PS Business Parks CEO Maria Hawthorne to retire, effective September 1 - PS Business Parks announced that Maria Hawthorne will retire as President and CEO of the company, effective September 1. Hawthorne has been on medical leave of absence due to health issues unrelated to COVID-19 since April 20. Hawthorne will continue to serve on the Board of Directors. John Petersen, the company's interim President and CEO and long-tenured COO, will continue in his role as interim President and CEO while the Board of Directors conducts an internal and external search for the company's next CEO. The company also announced that it has launched a search for a Chief Investment Officer as part of its ongoing efforts to expand the management team to focus on identifying strategic investment opportunities and driving growth. The Board of Directors has engaged the executive search firm of Korn Ferry to assist with identifying qualified candidates for both roles.

15:13 EDT DOJ announces settlement agreement with CenturyLink related to Level 3 order - The Department of Justice announced that CenturyLink has agreed to settle allegations that CenturyLink violated the court-ordered Final Judgment designed to prevent anticompetitive effects arising from its acquisition of Level 3 Communications, Inc. "Despite provisions in the Final Judgment barring CenturyLink from soliciting customers that switched to the buyer of the divestiture assets, CenturyLink failed to comply, initiating contact on over 70 occasions over more than a year with former Level 3 customers who elected to switch to the divestiture buyer in the Boise City-Nampa, Idaho MSA. CenturyLink does not deny the United States' allegations and has agreed to the Amended Final Judgment... As part of the settlement, CenturyLink has agreed to: extend the non-solicitation period by two years for the Boise MSA; the appointment of an independent monitoring trustee; and pay the United States to defray the costs of the department's investigation of CenturyLink's violations of the court order," the DOJ announced. Reference Link

14:38 EDT Starboard Value boosts Mednax, ACI Worldwide stakes, exits Resideo position - Jeffrey Smith's Starboard Value disclosed in an SEC filing its holdings as of June 30, 2020. Starboard's two new buys during the second quarter included, by size of position, iShares Russell 2000 ETF (IWM). Starboard exited one position during the quarter, Resideo (REZI). Starboard increased its stake in two holdings, including by size of previous position, Mednax (MD) and ACI Worldwide (ACIW). Starboard reduced its stake in eight holdings, including by size of previous position, eBay (EBAY), Cerner (CERN), NortonLifeLock (NLOK), and CommVault (CVLT). Starboard's top holdings as of June 30, in order of size, were NortonLifeLock, Advance Auto Parts (AAP), Aecom (ACM), Green Dot Corp. (GDOT), and Merit Medical Systems (MMSI).

14:23 EDT HTG Molecular says BioSpyder files lawsuit related to patent infringement claims - HTG Molecular Diagnostics provided an update regarding its patent infringement claims against BioSpyder Technologies. On August 13, BioSpyder filed a lawsuit seeking a declaration that it does not infringe HTG's U.S. Patent No. 8,741,564. In several previous communications between the companies, HTG had asserted its claims that BioSpyder's TempO-Seq gene expression tool infringes the '564 patent. "We believe our patents are strong, and we intend to vigorously enforce them just as any other IP-centric company would do. We had previously offered the possibility of arriving at a negotiated settlement that recognizes our patent rights, but BioSpyder was clearly not interested in that approach. We look forward to a fair and speedy resolution of our infringement claims," said John Lubniewski, President and CEO of HTG.

13:43 EDT Boot Barn promotes Greg Hackman to COO - Boot Barn has announced the promotion of Greg Hackman to Executive Vice President and Chief Operating Officer. Along with this additional role, Greg will continue in the role of CFO. "Mr. Hackman joined Boot Barn as Chief Financial Officer in 2015 and has been instrumental in Boot Barn's growth during the past five years. Greg's extensive retail industry experience and financial expertise have helped Boot Barn through a tremendous period of growth," said Jim Conroy, CEO of Boot Barn.

13:04 EDT Baker Hughes reports U.S. rig count down 3 to 244 rigs - Baker Hughes reports that the U.S. rig count is down 3 from last week at 244 with oil rigs down 4 to 172, gas rigs up 1 to 70, and miscellaneous rigs unchanged at 2. The U.S. Rig Count is down 691 rigs from last year's count of 935, with oil rigs down 598, gas rigs down 95, and miscellaneous rigs unchanged at 2. The U.S. Offshore Rig Count is up 1 to 13 and down 14 year-over-year. The Canada Rig Count is up 7 rigs from last week to 54, with oil rigs up 6 to 19, gas rigs up 1 to 35, and miscellaneous rigs unchanged at 0. The Canada Rig Count is down 88 rigs from last year's count of 142, with oil rigs down 82, gas rigs down 6 and miscellaneous rigs unchanged at 0.

13:00 EDT Baker Hughes reports U.S. rig count down 3 to 244 rigs

11:57 EDT Citi appointed as depositary bank for Freeline ADR programme - Citi said in a release, "Citi, acting through Citibank N.A., has been appointed by Freeline Therapeutics Holdings to act as depositary bank for its American Depositary Receipt, or ADR, programme. Freeline's American Depositary Shares, or ADS, trade on The Nasdaq Global Select Market under the symbol "FRLN." Each ADS represents one ordinary share of the company."

10:51 EDT Revlon seeks dismissal of lawsuit brought by UMB Bank - Revlon commented on litigation recently brought against the company by UMB Bank: "This is a baseless lawsuit brought by UMB - who has no standing to even sue - and directed by a group of desperate lenders seeking to enrich themselves by harming Revlon. We plan to seek dismissal of the suit and will continue to vigorously defend ourselves against these meritless accusations. Most importantly, we will continue to focus on successfully managing through the impacts of the global pandemic while executing against our strategic plan."

10:00 EDT Meredith falls -10.9% - Meredith is down -10.9%, or -$1.75 to $14.29.

10:00 EDT Linx S.A. rises 10.6% - Linx S.A. is up 10.6%, or 63c to $6.55.

10:00 EDT Farfetch rises 17.6% - Farfetch is up 17.6%, or $4.65 to $31.00.

09:47 EDT KE Holdings falls -8.8% - KE Holdings is down -8.8%, or -$3.30 to $34.14.

09:47 EDT Voxeljet falls -15.8% - Voxeljet is down -15.8%, or -$1.03 to $5.47.

09:47 EDT Dillard's rises 12.5% - Dillard's is up 12.5%, or $3.37 to $30.43.

09:28 EDT DraftKings guidance doesn't include college sports - Comments taken from Q2 earnings conference call.

09:20 EDT Pioneer Investments sends letter to shareholders regarding board nominees - Pioneer Floating Rate Trust announced that, in connection with its upcoming annual meeting of shareholders to be held on September 16, the fund is sending the following letter to shareholders: "We are writing to you again regarding this year's upcoming Annual Meeting of Shareholders, as it is vital you are aware of how the impressive qualifications and credentials of the gender-diverse slate of trustee nominees recommended by your Board stand in stark contrast to those of the hand-picked, all-male slate of nominees proposed by Saba Capital Management, L.P. Your Board unanimously recommends and strongly encourages you to vote on the WHITE proxy card "FOR ALL" of the Board's highly qualified and very experienced nominees - Diane P. Durnin, Benjamin M. Friedman, and Kenneth J. Taubes - and "AGAINST" Saba's proposal to terminate the Fund's investment advisory agreement with Amundi Pioneer Asset Management, Inc...In deciding to vote on the WHITE proxy card "FOR ALL" of the Board's highly qualified and very experienced nominees, we urge you to consider the following: As current Board members, the Board's nominees are deeply familiar with the Fund, its investment strategies, and its investment objective, as well as with the Fund's portfolio managers and other key personnel that manage the day-to-day operations of the Fund; That, as incumbent members of the Board, each of the Board's nominees has made significant contributions to the Board's deliberations and has proven that each has the integrity, knowledge, breadth of relevant and diverse experience, and proven commitment necessary to oversee the Fund as it continues to successfully execute on its investment objective; That each of the Board's nominees serves on the boards of trustees of other exchange-listed closed-end funds, closed-end interval funds, and open-end funds; That each of the Board's nominees has substantial experience protecting the interests of fund shareholders; That each of the Board's nominees, as part of their service as trustees on the boards of multiple closed-end funds, has experience regularly evaluating issues unique to closed-end funds, including the strategies for mitigating the discount at which closed-end funds' shares may trade relative to their net asset value per share ("NAV"); That the election of the Board's nominees will promote the continuity of the Fund's oversight and governance, which the Board believes is critical as the Board navigates the Fund through an unprecedented period of macroeconomic uncertainty and market volatility driven by heightened concerns about the COVID-19 global pandemic... Don't be fooled by Saba and its attempt to have you believe its proxy contest and its proposed slate of nominees are intended to improve the Fund and its returns. We have little doubt that Saba, through its proxy contest and its proposed nominees, is not seeking to enhance the Fund's performance or the ability of the Fund to meet its stated investment objective. We believe that Saba's proxy contest is nothing more than a transparent tactic intended to facilitate Saba's ability to "hijack" the Fund and force a liquidity event, possibly even a complete liquidation of the Fund, that results in all of Saba's shares being cashed-out at a per share price that approximates NAV, an outcome that would provide Saba with a quick profit but one that could make the Fund less viable and less able to meet its investment objective of providing investors with a high level of current income. Preserve your Fund's future and its viability as an investment vehicle for those investors seeking a high level of current income by opposing Saba's self-serving proxy contest, the three candidates Saba handpicked from its nominee "bullpen," and Saba's potentially devastating proposal to terminate the Fund's investment advisory agreement. Your vote is important, no matter how many shares you own. Your Board unanimously recommends that shareholders vote on the WHITE proxy card "FOR ALL" of the Fund's highly qualified and very experienced nominees, all of whom are valued members of your Board, and "AGAINST" Saba's proposal to terminate the Fund's investment advisory agreement with Amundi Pioneer. You may also vote by telephone or Internet by following the instructions on the enclosed WHITE proxy card. Your Board encourages you to vote each WHITE proxy card you receive..."

09:13 EDT SAIC announces retirement of CFO Charles Mathis - SAIC said in a release, "Science Applications International announced the retirement of CFO Charles Mathis. Mathis will remain with the company through fiscal year 2021, ending January 29, 2021, to ensure a smooth transition as the company conducts a search for a successor. Mathis joined the company in November 2016 as executive vice president and CFO."

09:12 EDT Apple Hospitality REIT acquires Hyatt House, Hyatt Place in Tempe, AZ for $64.6M - Apple Hospitality REIT said in a release, "Apple Hospitality REIT announced the opening and acquisition of the new 105-room Hyatt House and 154-room Hyatt Place in Tempe, Arizona, for a gross purchase price of approximately $64.6 million, or approximately $249,000 per key. Following this acquisition, the Apple Hospitality portfolio includes 235 hotels with more than 30,000 guest rooms geographically diversified throughout 34 states."

09:04 EDT Adamis announces pre-IND feedback from FDA on Tempol - Adamis Pharmaceuticals Corporation announced that in response to Adamis' Pre-Investigational New Drug filing with the U.S. Food and Drug Administration, the FDA has provided detailed comments regarding the prospective use of Tempol in a randomized placebo controlled trial. The FDA's response now allows Adamis to proceed to the next step of formally submitting an IND for Tempol, and at the same time, begin formal applications for funding to governmental agencies to support the clinical trial and large-scale manufacturing.

08:58 EDT Charles Schwab reports July core new assets $2.7B - Charles Schwab released its monthly activity report. Core net new assets brought to the company by new and existing clients totaled $2.7B. Core net new assets excluding mutual fund clearing totaled $2.4B. These flows reflect the extension of the federal income tax filing due date from April 15 to July 15. Total client assets were $4.28T as of month-end July, up 14% from July 2019 and up 4% compared to June. New brokerage accounts were 206,000 in July, up 60% from July 2019 and up 2% compared to June.

08:49 EDT Vaccinex announces upcoming expected milestones - Late September/Early October 2020 - Topline data expected from potentially pivotal SIGNAL Huntington's disease study. September 2020 - Anticipated enrollment of first patient in Alzheimer's disease Phase 1/2 study. Second half 2020 - Preparation expected to commence for Phase 2 study of pepinemab in combination with anti-PD-1 in head and neck cancer. "We are rapidly approaching a significant milestone for our company with top-line data from our potentially pivotal SIGNAL trial in Huntington's disease expected by early October," stated Maurice Zauderer, Ph.D., president and chief executive officer of Vaccinex. "In parallel, we are exploring pepinemab's potential utility in other slowly progressive neuroinflammatory and neurodegenerative diseases and anticipate commencing enrollment in a Phase 1/2 Alzheimer's disease trial in September. We are very appreciative of financial support from both the Alzheimer's Association and from the Alzheimer's Drug Discovery Foundation to advance this important trial," Dr. Zauderer concluded.

08:48 EDT Vaccinex to offer further details on pepinemab study in head, neck cancer in Q3 - The company is preparing to initiate a new study of pepinemab in combination with an anti-PD-1 checkpoint inhibitor to treat front line head and neck cancer. The Company expects to provide further details on this study in the third quarter of 2020.

08:42 EDT Ebang establishes subsidiary in Singapore in preparation for crypto exchange - Ebang International Holdings announced that on August 13, 2020, it has established a wholly-owned subsidiary in Singapore in preparation for establishing a cryptocurrency exchange. The company said, "As our next step, we plan to seek the relevant governmental approval and license to operate the cryptocurrency exchange and related business. However, there is no guarantee that we will receive such approval and license on commercially reasonable terms, or at all, or that we will commence the purposed business as planned, or at all. Shareholders are cautioned not to place undue reliance on this press release."

08:40 EDT Freshpet launches multi-year corporate governance plan - Freshpet launched a multi-year plan to enhance its corporate governance practices, as described in detail in the definitive proxy statement filed with the Securities and Exchange Commission in connection with Freshpet's 2020 Annual Meeting of Shareholders. Highlights from Freshpet's Commitment to Good Corporate Governance as described in the 2020 Proxy Statement are as follows: 2020 Proposal to Shareholders and Board Action: Board Proposal to Eliminate All Supermajority Voting Provisions from our Certificate of Incorporation In this year's Proxy Statement, our Board has submitted a proposal to be voted on by shareholders to eliminate all of the supermajority voting provisions from the Company's Certificate of Incorporation. Planned Future Proposals and Board Actions Director Resignation Policy After this year's Annual Meeting and contingent upon the shareholders' approval of the Supermajority Voting Removal Proposal, the Board plans to adopt a policy that any incumbent nominee for director who does not receive the affirmative vote of a majority of the votes cast in any uncontested election must promptly offer to resign. The Nominating and Corporate Governance Committee will make a recommendation on the offer and the Board will decide whether to accept or reject the offer. Majority Voting Standard for Director Elections Before the Company's 2021 Annual Meeting, the Board plans to amend our Bylaws to implement a majority voting standard for director elections in uncontested elections and a plurality voting standard in contested elections. Our current Bylaws provide for a plurality voting standard. Director Retirement Policy Before the Company's 2021 Annual Meeting, our Board plans to adopt a director retirement policy that will provide that non-employee directors may not stand for re-election to the Board after reaching age 75. Board Proposal to Declassify the Board of Directors In the Company's 2021 Proxy Statement, our Board plans to submit a proposal to be voted on by stockholders to fully declassify the Board by 2025. Our Certificate of Incorporation currently divides our Board into three classes, with one class being elected each year. Proxy Access Before the Company's 2022 Annual Meeting, the Board plans to amend the Company's Bylaws incorporating a provision to permit a stockholder, or a group of up to 20 shareholders, owning at least 3% of our outstanding common stock for three years, to nominate a certain percentage of the directors for the Company's Board. Stockholder Right to Call a Special Meeting In the Company's 2022 Proxy Statement, our Board plans to submit a proposal to be voted on by stockholders at the 2022 Annual Meeting to allow stockholders the ability to call special meetings.

08:36 EDT Green Growth Brands provides CCAA, other updates - Green Growth Brands and certain of its direct and indirect wholly owned subsidiaries provided an update on their insolvency proceedings under the Companies' Creditors Arrangement Act. As previously announced, the Applicants sought and were granted protection under the CCAA by the Ontario Superior Court of Justice on May 20, 2020. On June 2, 2020, the Court granted certain additional relief, including an order that, among other things: approved the implementation of a sale and investment solicitation process; and approved a stalking-horse agreement made as of May 19, 2020 between the Company, All Js Greenspace LLC and Capital Transfer Agency, ULC in its capacity as the debentureholder trustee of the Company's $45,500,000 aggregate principal amount of 15.00% secured convertible debentures that matured May 17, 2020 and $23,717,000 aggregate principal amount of 5.00% secured convertible debentures maturing in 2024 pursuant to which the Purchaser would act as the stalking-horse bidder under the SISP. The SISP did not result in a Superior Offer. As such, and in accordance with the terms of the SISP, Ernst & Young Inc., in its capacity as the Court-appointed monitor of the Applicants, recommended that the SISP be terminated. The Company issued a press release to this effect on July 22, 2020. On August 13, 2020, the Court granted two orders that, among other things, approved the sale transaction contemplated by the Stalking Horse Agreement, as amended and restated by the Amended and Restated Acquisition Agreement dated August 10, 2020 between the Company and the Purchaser; approved the vesting in an entity to be incorporated all of the Company's right, title and interest in and to all of the Purchased Assets, which include all of the shares of GGB Canada Inc., all of the shares of Xanthic Biopharma Limited, certain intercompany indebtedness and certain books and records; approved an amendment dated August 10, 2020 to the debtor-in-possession term sheet between the Company and All Js dated May 19, 2020; and extended the stay of proceedings under the CCAA until and including December 18, 2020. The Transaction is structured as a credit bid. The Monitor estimates that the approximate aggregate purchase price pursuant to the Amended and Restated Stalking Horse Agreement is $106,388,429. The Transaction remains subject to the satisfaction of certain conditions to closing, some of which remain outstanding and include the transfer of certain cannabis licenses. The Company also announced that on July 29, 2020, its subsidiary, Nevada Organic Remedies, reached a partial settlement regarding the previously disclosed Nevada cannabis license litigation. The License Litigation challenged, among other things, the manner and method by which the state of Nevada's Department of Taxation reviewed and awarded applications for conditional retail cannabis dispensary licenses. NOR received seven Conditional Licenses pursuant to the application process in December 2018 but was prevented from receiving final approval pursuant to an August 2019 preliminary injunction. Under the terms of the Settlement, NOR and the other successful applicants have agreed to assign certain licenses to the unsuccessful parties in exchange for, among other things, dismissal with prejudice of the relevant actions brought by the settling plaintiffs, removal of NOR and the other settling defendant-intervenors from the scope of the Preliminary Injunction and expedited inspection and approval for dispensary locations. On August 7, 2020, the Cannabis Compliance Board of the state of Nevada approved the Settlement. The Settlement will allow NOR to expedite the opening of its Reno location, and will allow for the future opening of dispensary locations in the City of Las Vegas, the City of North Las Vegas, the city of Henderson and Nye County. The Company further announced that a cease trade order was issued by the Ontario Securities Commission on July 29, 2020 as a result of the Company's failure to file its interim financial statements for the three months ended March 31, 2020, including the related management discussion and analysis and interim filing certifications. In connection with the cease trade order, the Canadian Securities Exchange suspended trading of the Company's shares effective July 30, 2020.

08:33 EDT CACI awarded $128M task order from U.S. Army PEO Soldier - CACI said in a release, "CACI International announced that it has been awarded a five-year, single-award task order, with a ceiling value of nearly $128 million, to provide mission expertise, including training and field service support to the U.S. Army Program Executive Office for Soldier (PEO Soldier) on maneuver, precision targeting and visual augmentation systems. CACI will provide the mission expertise to PEO Soldier's Project Manager Soldier Maneuver and Precision Targeting (PM SMPT) and Project Manager Integrated Visual Augmentation Systems (PM IVAS) to maximize soldier lethality, mobility, and situational awareness. That includes developing and conducting new equipment training, as well as providing rapid field service support for a wide-range of systems, such as the Integrated Visual Augmentation System, Thermal Weapon Sight, Enhanced Night Vision Goggles, Lightweight Laser Designator Rangefinder, and other soldier-borne systems that use imaging and laser technologies."

08:17 EDT USA Technologies appoints Wayne Jackson as CFO - USA Technologies (USAT) announced that Wayne Jackson has joined the company as CFO, effective immediately. He will be based in USAT's Atlanta office. Jackson will oversee the finance organization and lead all aspects of the company's financial strategy and operations, including budgeting and planning, treasury, accounting, tax and financial reporting. He joins USA Technologies after serving four years as the CFO of Secureworks (SCWX).

08:17 EDT Snap Lens Studio announces 2D Full Body Tracking - Snap said on its website: "The latest Lens Studio update lets you reimagine what it means to move. With the arrival of 2D Full Body Tracking, you can now create Lenses that move with your entire body. In technical terms, this means you'll have the ability to track 18 joints and trigger effects based on those body movements - legs included! This feature will be especially useful as you level up your next dance challenge, workout tutorial, or whatever's keeping you moving these days!" Reference Link

08:10 EDT E-Trade reports July DARTs up 288% y/y - E-Trade released its monthly activity report for July and also provided an update for August to-date trading activity. Daily average revenue trades, or DARTs, for July were 1,014,000, and derivative DARTs were 273,000. Trading volume has increased in August, with DARTs of 1,084,000 and derivative DARTs of 291,000 through August 12.

08:08 EDT Celsion sees cash sufficient to fund operations into 4Q21 - The Company ended the second quarter of 2020 with $25.5 million in cash, investment securities and accrued interest receivable. With $25.5 million in cash as of June 30, 2020 coupled with future sales of the Company's New Jersey NOL's, the Company believes it has sufficient capital resources to fund its operations into the fourth quarter of 2021.

08:06 EDT WNS Holdings announces contract with EV Cargo to build, manage F&A operations - WNS Holdings announced a strategic contract win with EV Cargo, a global logistics company providing supply chain services. EV Cargo is partnering with WNS to build and manage an integrated finance and accounting, or F&A, operations solution for its expanding worldwide business. WNS will leverage its shipping and logistics experience and F&A expertise to help EV Cargo build a consolidated operating model including a shared services center, and provide support in designing their new financial enterprise resource planning system.

08:03 EDT Front Yard Residential announces termination of asset management agreement - Front Yard Residential Corporation (RESI) announced that the Company and Altisource Asset Management Corporation (AAMC) have agreed to terminate their existing asset management agreement pursuant to which AAMC has performed management services for Front Yard, facilitating the Company's transition from an externally-managed REIT to an internally-managed REIT. On August 13, 2020, the parties entered into a termination and transition agreement, which provides for the termination of the AMA following a transition period and governs the acquisition by Front Yard of the operations of AAMC related to the management of Front Yard's business. Front Yard's board of directors anticipates a smooth and timely transition of all functions necessary to complete the Internalization pursuant to an agreed upon transition plan specified in the Termination Agreement. In connection with the Termination Agreement, Front Yard will pay an aggregate termination fee of $46M to AAMC, consisting of an upfront payment of $15,000,000 in cash, $15,000,000 in cash on the date that the parties mutually agree that the transition is complete and $16,000,000 in cash or common stock of the Company, at the Company's election, on the Termination Date. During the transition period, the Company will continue to pay AAMC the base management fee provided for in the existing AMA and a pro rata portion of the base management fee for any partial calendar quarter during such period, until such time as Front Yard determines that the transition has been completed. In addition, in connection with the Internalization, Front Yard will acquire, at its election, either the equity interests or assets of AAMC's Indian subsidiary, the equity interests of AAMC's Cayman Islands subsidiary, the right to solicit and hire designated AAMC employees that currently oversee the management of Front Yard's business and other assets of AAMC that are used in connection with the operation of Front Yard. The purchase price for the Acquired Assets is $8,200,000, consisting of an upfront payment of $3,200,000 in cash and $5,000,000 in cash or common stock of the Company, at the Company's election, on the Termination Date. AAMC has agreed to immediately reinstate George Ellison and Robin Lowe in their roles as co-CEO and CFO of AAMC, respectively, and has reinstated their base compensation retroactively from June 9, 2020.

08:02 EDT Rocket Companies jumps 6% to $19.92 after reporting preliminary Q2 results

07:41 EDT Ocugen expects workforce reduction to result in $2M in annualized cost savings - In June 2020, after review of a pre-planned interim sample size analysis which indicated the trial was unlikely to meet its co-primary endpoints upon completion, Ocugen discontinued the Phase 3 trial and initiated a workforce reduction as part of this shift in focus towards its gene therapy platform and novel biologics program aimed at curing blindness diseases. Ocugen expects the workforce reduction will result in approximately $2M in annualized cost savings commencing in 2021.

07:39 EDT AstraZeneca reports pact with EC for supply of up to 400M doses of COVID vaccine - AstraZeneca announced it has concluded an agreement with the European Commission to supply up to 400 million doses of the AZD1222 COVID-19 vaccine. "Building on the existing agreement with Europe's Inclusive Vaccines Alliance spearheaded by Germany, France, Italy and the Netherlands, this new agreement will give all EU member states the option to access the vaccine in an equitable manner at no profit during the pandemic. It also allows EU member states to redirect doses to other European countries," the company said. CEO Pascal Soriot added: "This first vaccine agreement with the European Commission will ensure that millions of Europeans have access to the AZD1222 vaccine following its approval. With production in our European supply chain soon to be started, we hope to make the vaccine available widely and rapidly, with the first doses to be delivered by the end of 2020. I would like to thank the entire European Commission, and especially the Commissioner for Health and Food Safety, Stella Kyriakides, for their swift response in ensuring Europeans may soon be protected with a vaccine against this deadly virus, enabling our global society and economy to rebuild."

07:35 EDT KemPharm participates in KP415 mid-cycle communication meeting with FDA - KemPharm announced that the Company participated in a mid-cycle communication meeting on August 13, 2020, with the U.S. Food and Drug Administration regarding the ongoing review of the New Drug Application for KP415, KemPharm's investigational product candidate for the treatment of attention deficit hyperactivity disorder. The FDA did not raise any substantive issues at the meeting and indicated that no major safety concerns have been noted at this point in their review. Additionally, the PDUFA date of March 2, 2021, was re-affirmed. The FDA also tentatively scheduled a late-cycle communication meeting to be held on December 1, 2020, if needed. Since KP415 is based on the new molecular entity, serdexmethylphenidate, KemPharm's prodrug of d-methylphenidate, the KP415 NDA is subject to the provisions of "the Program" under the Prescription Drug User Fee Act VI, which provides for several communication meetings to be held between the FDA and the NDA sponsor throughout the review process to aid the FDA in their review and to provide timely feedback to the sponsor. In September 2019, KemPharm entered into the License Agreement with an affiliate of Gurnet Point Capital for the exclusive worldwide rights to develop, manufacture and commercialize KemPharm's product candidates containing SDX, including KemPharm's ADHD product candidates, KP415 and KP484. GPC's portfolio company, Corium, Inc., will lead all commercialization activities for KP415.

07:14 EDT SCWorx appoints Timothy Hannibal as president, COO - SCWorx announced the appointment of Timothy Hannibal as president, COO and director. Hannibal, currently the company's CRO and Interim CFO, will report to the Board of Directors and be responsible for overseeing the day to day operations of the Company, including financial operations.

07:12 EDT BioXcel expects data from Phase 1b/2 study of BXCL701 later this year - The Phase 2 portion of the Phase 1b/2 trial of BXCL701 in combination with pembrolizumab for treatment emergent Neuroendocrine Prostate Cancer is advancing on track. Recently, BTI expanded the trial to include a separate cohort for CRPC patients who have failed taxane-based chemotherapy and up to two lines of second generation androgen pathway blockers, based on preliminary evidence of activity in this patient population in the safety cohort. The CRPC cohort is expected to run concurrently with the tNEPC cohort. Initial efficacy data from this trial are expected to be reported later this year. The open label Phase 2 basket trial evaluating the combination of BXCL701 and KEYTRUDA in patients with advanced solid cancers is proceeding, with early signs of clinical activity in several difficult-to-treat cancers. This study, which is being conducted at the MD Anderson Cancer Center, consists of two arms: checkpoint naive patients and patients who are refractory to checkpoint therapy. In June, the safety portion of the trial was completed and in August, the efficacy bar was met for both arms of the trial, allowing the study to proceed to completion. Initial efficacy data are expected to be presented at a scientific conference later this year. The BXCL701 phase of the triple combination study of BXCL701, bempegaldesleukin and BAVENCIO in second line pancreatic cancer is expected to begin following Nektar and Pfizer's Phase 1b safety trial of a double combination of bempegaldesleukin and avelumab, pending the outcome of that trial.

07:07 EDT Imara expects cash to be sufficient to fund operations into mid-2022 - The Company currently expects that its full-year 2020 research and development expenses will range between $35M and $40M and that its full-year 2020 general and administrative expenses will range between $8M and $10M. The Company expects that its cash, cash equivalents and investments as of June 30, 2020, will be sufficient to enable it to fund its planned operations into mid-2022.

07:00 EDT MSG Entertainment implements workforce reduction, cost cuts - The company stated, "Over the first eight months of fiscal 2020, the Company was experiencing positive momentum across its operations. The 2019 season of the Christmas Spectacular Starring the Radio City Rockettes marked the show's highest grossing run ever. The Company's entertainment and sports bookings business was on track for a record number of events for the fiscal year and Tao Group Hospitality was delivering strong year-over-year growth. In addition, the Company was making significant progress on a number of important initiatives, including the construction of its MSG Sphere venue in Las Vegas and the completion of both the spin-off transaction and the $400 million sale of the Forum in Inglewood, California. As a result of the COVID-19 pandemic, in mid-March, the Company's performance venues and Tao Group Hospitality's entertainment dining and nightlife venues were closed, and, except for certain Tao Group Hospitality venues, remain closed today. The Boston Calling Music Festival, scheduled for Memorial Day weekend, was canceled. And last week, the Company canceled its Christmas Spectacular production for this upcoming holiday season as a result of the ongoing uncertainty. Following the shutdown of its venues in March, the Company took immediate steps to reduce discretionary spending and made several difficult decisions. Tao Group Hospitality eliminated essentially all its venue line staff and manager positions. The Company also ended financial support of event-level employees at its performance venues at the end of May. The Company has continued to review its operations and last week implemented additional actions, including a workforce reduction and significantly reduced spending across all departments. The Company's MSG Sphere venue in Las Vegas is also impacted. In April, the Company announced that it was suspending construction of MSG Sphere due to COVID-19 related factors that were outside of its control, including supply chain issues. As the ongoing effects of the pandemic have continued to impact its operations, the Company has revised its processes and construction schedule, and has resumed work with a lengthened timetable that enables the Company to better preserve cash in the near-term. The Company remains committed to bringing MSG Sphere to Las Vegas and, based on its new construction schedule, now expects to open the venue in calendar 2023. The Company has taken these steps to conserve cash and believes it is well positioned to navigate the temporary shutdown. As of June 30, 2020, the Company had approximately $1.2 billion in cash and short-term investments. Debt outstanding consisted of a $33.8 million bank term loan at Tao Group Hospitality. The Company's cash and cash equivalents at fiscal year-end included approximately $200 million in deferred revenue and collections due to promoters, primarily related to tickets, suites and sponsorships - all of which will be addressed, to the extent necessary, through credits, make-goods, refunds and/or rescheduled dates. As of June 30, 2020, the significant majority of deferred ticket revenue was related to events that have been or are expected to be rescheduled into calendar 2021. Ticketholders for rescheduled events have primarily opted to retain their tickets, and the Company is providing ticket refunds as appropriate."

06:32 EDT Marathon Patent Group to purchase 10,500 miners from Bitmain - Marathon Patent Group has entered into a $23M Long Term Purchase Contract with Bitmain for the purchase of 10,500 next generation Antminer S-19 Pro ASIC Miners. Additionally, 1,360 Miners were delivered to Marathon's Hosting Facility today, and the company anticipates that all of these Miners will be deployed and added to its current 700 Miners presently in operation, bringing currently installed Miners to 2,060 which will produce 184.6 PH/s. Bitmain will also deliver 500 previously purchased S-19 Pro Miners in September and 500 in November. After the installations this weekend go operational next week, the company's yields are expected to generate prospective positive net cash flow, based on the current price of Bitcoin and Hashrate difficulty.

06:20 EDT Farmmi receives new customer orders for export to U.S., Canada - Farmmi said in a release, "Farmmi announced its subsidiary Zhejiang Forest Food has received new customer orders for its dried whole mushrooms and dried mushroom slices. The customer, an investment trading company, will export the mushrooms to the U.S. and Canada."

05:48 EDT SEC charges former Hertz CEO with aiding financial reporting violations - The SEC has charged former Hertz CEO and Chairman Mark Frissora with aiding and abetting the company in its filing of inaccurate financial statements and disclosures. Frissora has agreed to settle the charges and repay Hertz nearly $2M in incentive-based compensation. The SEC's complaint alleges that as Hertz's financial results fell short of its forecasts throughout 2013, Frissora pressured subordinates to "find money," principally by re-analyzing reserve accounts, causing Hertz's staff to make accounting changes that rendered the company's financial reports materially inaccurate. According to the complaint, Frissora also led Hertz to hold rental cars in its fleet for longer periods and thus lower its depreciation expenses, without properly disclosing the change - and the risks of relying on older vehicles - to investors. Without admitting or denying the allegations, Frissora consented to a judgment permanently enjoining him from aiding and abetting any future violations of the applicable federal securities laws, requiring him to reimburse Hertz for $1,982,654 in bonus and other incentive-based compensation and requiring him to pay a $200,000 civil penalty. The settlement is subject to court approval.

05:35 EDT Daimler reaches pact in principle to settle US emissions claims - Daimler AG and its subsidiary Mercedes-Benz USA LLC have reached an agreement in principle with various U.S. authorities to settle civil and environmental claims regarding emission control systems of approx. 250,000 diesel passenger cars and vans in the United States. The involved U.S. authorities are the Environmental Protection Agency, the California Air Resources Board, the Environment and Natural Resources Division of the U.S. Department of Justice, the California Attorney General's Office, and the U.S. Customs and Border Protection. The company has cooperated fully with the U.S. authorities and continues to do so. Daimler AG and MBUSA have also reached an agreement in principle with plaintiffs' counsel to settle the consumer class action "In re Mercedes-Benz Emissions Litigation," which is pending before the U.S. District Court for the District of New Jersey. For the settlements with the U.S. authorities, Daimler expects costs of approx. $1.5B. The estimated cost of the class action settlement is approx. $700M including the court's anticipated award of attorneys' fees and costs. In addition, Daimler estimates further expenses of a mid three-digit-million EUR amount to fulfill requirements of the settlements. Daimler expects a corresponding impact on the Free Cash Flow of the industrial business over the next 3 years with the main impact within the next 12 months. The settlements are subject to the final approval of the relevant authorities and courts.